Marijuana Reclassification: What Business Owners Need to Know About Trump's New Policy

April 23, 2026 - 23:31

In a significant shift in federal drug policy, former President Donald Trump has officially reclassified marijuana under the Controlled Substances Act, moving it from Schedule I to Schedule III. This change, long sought by cannabis advocates and industry stakeholders, carries profound implications for business owners operating in the legal marijuana sector.

Under Schedule I classification, marijuana was grouped with heroin and LSD, defined as having no accepted medical use and a high potential for abuse. Schedule III, which includes substances like Tylenol with codeine and anabolic steroids, acknowledges moderate to low potential for dependence. For business owners, the most immediate impact is financial. Previously, Section 280E of the Internal Revenue Code prohibited cannabis businesses from deducting standard business expenses—such as rent, payroll, and utilities—because they were trafficking in a Schedule I substance. This created an effective tax rate often exceeding 70 percent for many operators. With the reclassification, cannabis companies can now claim these deductions, potentially slashing their tax burdens and freeing up capital for expansion, compliance, and employee benefits.

However, the change does not legalize marijuana federally. States retain authority over recreational and medical sales, and banking restrictions remain in place. Business owners must still navigate a patchwork of state laws and federal enforcement priorities. Additionally, the reclassification may trigger new regulatory requirements from the Food and Drug Administration, including quality control standards and labeling mandates. For entrepreneurs, this is a moment of cautious optimism: lower taxes improve profitability, but the industry remains far from normalized. As the policy takes effect, savvy business owners should consult tax professionals and legal advisors to adjust their accounting practices and prepare for potential federal oversight.